Lopez
Lopez v. Baxter Healthcare Corp.
Opinion
Lead Opinion
ORDER
Numerous federal lawsuits have been filed against Baxter Healthcare Corporation alleging the defective manufacture of Baxter’s product, Gammagard. The Judicial Panel on Multi-District Litigation consolidated all of the lawsuits and transferred them to the United States District Court for the Central District of California solely for coordinated pre-trial proceedings. The cases were assigned to the Honorable Manuel L. Real in Los Angeles.
Judge Real entered a number of pretrial orders in these cases. The one in question is Case Management Order (“CMO”) No. 7 in which Judge Real created a “Plaintiffs’ Executive Committee” to oversee two funds to which all of the Baxter plaintiffs are required to contribute — a “litigation expense fund” and a “counsel fee fund.” Intended as a mechanism to coordinate and share the cost of discovery, CMO No. 7 requires plaintiffs’ counsel in each of the consolidated cases to deposit $7,500.00 into the litigation expense fund, and six percent of whatever they recover against Baxter into the counsel fee fund (up to a maximum counsel fee contribution of $75,000.00). The order contains a refund provision that will apply to funds left over at the…